Saturday 17 October 2026
Export BRKR’s income statement to Excel — free account
Bruker Corporation
BRKR Healthcare Medical Devices
Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024. In the quarter to June 2026, revenue grew 5.15%, EPS fell 920.0%, free cash flow grew 28.6% and total debt fell 25.1%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five.
54.80
1.74
−3.08%
Follow BRKR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 3 | 4 | 4 |
+8 more TTM periods Free account |
| (5.07%) | (1.69%) | (1.05%) | (1.11%) | ||
| (1.73%) | (0.60%) | (0.37%) | (0.38%) | ||
ROIC |
(0.47%) | 0.73% | 1.05% | 0.96% | |
Return on Tangible Assets |
(6.16%) | (2.48%) | (1.34%) | (1.30%) | |
Average Days of Receivables |
56.94 | 57.28 | 57.88 | 58.47 | |
Free Cash Flow per Share |
0.62 | 0.34 | 0.29 | (0.07) | |
Free Cash Flow |
93.90 | 51.30 | 43.30 | (10.60) | |
Capital Expenditures |
(96.50) | (89.00) | (90.80) | (104.90) | |
| Other line items | |||||
Cash ROIC |
2.13% | 1.20% | 0.93% | (0.22%) | |
Accounts Receivable Turnover |
6.55 | 6.40 | 6.19 | 6.31 | |
Accounts Payable Turnover |
8.46 | 7.37 | 8.26 | 8.82 | |
Inventory Turnover |
1.60 | 1.69 | 1.72 | 1.50 | |
Average Days of Payables |
38.97 | 51.91 | 42.39 | 37.04 | |
Days of Inventory on Hand |
218.02 | 216.33 | 214.94 | 240.36 | |
Tax Rate |
1.80 | (1.23) | (1.33) | (3.25) | |
Research and Development Expense of Revenue |
11.24% | 11.55% | 11.50% | 11.63% | |
Selling, General and Administrative Expense of Revenue |
27.74% | 27.85% | 27.54% | 27.53% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 2.22% | 0.00% | |
Operating CF/Net income |
(1.78) | (3.85) | (5.96) | (3.98) | |
Depreciation/Fixed assets |
0.32 | 0.32 | 0.30 | 0.29 | |
Capex/Depreciation |
(0.42) | (0.39) | (0.41) | (0.49) | |
Revenue per Share |
22.98 | 22.72 | 22.64 | 22.65 | |
Operating CF per Share |
1.25 | 0.92 | 0.88 | 0.62 | |
Capex per Share |
(0.63) | (0.58) | (0.60) | (0.69) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates